IBT International Biotechnology Ord
LSE · GB · Healthcare
1065.00GBp-0.93%Mkt Cap: 366.42M $P/E: 4.40Today
Industry Peers
HealthcareKey Statistics
Company
Market Cap366.42M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.27M USD
Revenue/Share—
Last Price1065.00 GBp
Fiscal Year End—
MR Quarter—
Employees—
CountryGB
SectorHealthcare
Industry—
ISIN—
Valuation
P/E (Trailing)4.40
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.09
EPS (TTM)—
EPS (Forward)—
52W Range
770.0063% of range1235.00
52W High1235.00 GBp
52W Low770.00 GBp
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin668.57%
ROE-0.47%
ROA-0.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF31.12M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.12
Current Ratio—
Quick Ratio—
Book Value/Sh9.88 GBp
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.32 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.31.65M
Float—
Insiders—
Institutions—
Technical
SMA 501099.00 (-3.1%)
SMA 2001003.60 (+6.1%)
Beta—
S&P 52W Chg—
Avg Vol (30d)69.32K
Avg Vol (10d)57.83K
Technical Indicators
RSI (14)41.1
MACD-2.2031
MACD Signal1.3561
MACD Hist.-3.5591
BB Upper1132.63 GBp
BB Middle1107.00 GBp
BB Lower1081.37 GBp
BB Width4.63%
ATR (14)32.38 GBp
Vol Ratio (20d)0.74x